Journal profile · ALLERGY
Allergy Asthma & Respiratory Disease
ISSN 2288-0402 · eISSN 2288-0410
Allergy Asthma & Respiratory Disease: CAS Zone 4 · Medicine (2025 upgraded edition); fully open access; median 45 days to acceptance (49 articles, last 24 months); 29 articles in 2025; indexed in ESCI.
Scope
Aims, scope and focus
Allergy Asthma & Respiratory Disease is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Asthma and respiratory diseases, Allergic Rhinitis and Sensitization and Food Allergy and Anaphylaxis Research, together about 35.2% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Research area (LetPub): ALLERGY
Main research topics OpenAlex counts of recent articles; shares are approximate
- Asthma and respiratory diseasesMedicine14.3%
- Allergic Rhinitis and SensitizationMedicine12.8%
- Food Allergy and Anaphylaxis ResearchMedicine8.1%
- Pediatric health and respiratory diseasesHealth Professions5.3%
- Dermatology and Skin DiseasesMedicine5.2%
- Drug-Induced Adverse ReactionsMedicine5.2%
- Contact Dermatitis and AllergiesMedicine5.1%
- Respiratory and Cough-Related ResearchMedicine4.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Allergy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Allergy | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCILetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- h-index
- 14OpenAlex ·
- i10-index
- 39OpenAlex ·
- 2-year mean citedness
- 0.44OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 24LetPub ·
Articles by year OpenAlex count · 847 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 25 | 25 | 1 |
| 2025 | 29 | 29 | 9 |
| 2024 | 32 | 32 | 28 |
| 2023 | 33 | 33 | 28 |
| 2022 | 40 | 40 | 45 |
| 2021 | 41 | 41 | 54 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
45 daysMedian, submission to acceptance · P25–P75 28 days – 63 days
- Acceptance to online
- median 154 days (49 articles)
- Submission to online
- median 199 days
- Sample
- 49 articles with submission and acceptance dates (54 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- ISSN
- 2288-0402
- Electronic ISSN
- 2288-0410
FAQ
Frequently asked questions about Allergy Asthma & Respiratory Disease
What CAS zone is Allergy Asthma & Respiratory Disease in?
In the 2025 upgraded edition of the CAS Journal Ranking, Allergy Asthma & Respiratory Disease is in Zone 4 of Medicine, and in Zone 4 of the minor category Allergy. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
How long does peer review take at Allergy Asthma & Respiratory Disease?
Based on the dates recorded on 49 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 45 days (interquartile range 28–63 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Allergy Asthma & Respiratory Disease?
According to LetPub and DOAJ records, Allergy Asthma & Respiratory Disease is indexed in ESCI.
Is Allergy Asthma & Respiratory Disease open access, and what is the APC?
Allergy Asthma & Respiratory Disease is a fully open-access journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .